Holen Sie sich die Stockscreener-App
2.04
2.51%
0.05
Vorhandelsmarkt:
2.11
0.07
+3.43%
Schlusskurs vom Vortag:
$1.99
Offen:
$2.01
24-Stunden-Volumen:
163.26K
Relative Volume:
0.84
Marktkapitalisierung:
$7.02M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
-1.2439
EPS:
-1.64
Netto-Cashflow:
$-23.84M
1W Leistung:
+7.94%
1M Leistung:
+41.67%
6M Leistung:
-54.16%
1J Leistung:
-85.59%
1-Tages-Spanne:
$1.94
$2.05
1-Wochen-Bereich:
$1.8926
$2.17
52-Wochen-Spanne:
$1.3381
$19.00
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MYNZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
2.04 | 7.59M | 895.50K | -26.30M | -23.84M | -1.64 |
|
TMO
Thermo Fisher Scientific Inc
|
478.32 | 179.32B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.48 | 145.22B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
565.19 | 44.23B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
199.17 | 34.14B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.18 | 34.19B | 6.63B | 1.17B | 1.19B | 4.05 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
What is the risk reward ratio of investing in Mainz Biomed N.V. stockCapitalize on market trends with expert guidance - jammulinksnews.com
How does Mainz Biomed N.V. compare to its industry peersExplosive wealth accumulation - jammulinksnews.com
What is the dividend policy of Mainz Biomed N.V. stockBuild wealth steadily with smart trading - jammulinksnews.com
How strong is Mainz Biomed N.V. company’s balance sheetFree Stock Market Return Analysis - jammulinksnews.com
What catalysts could drive Mainz Biomed N.V. stock higher in 2025Accelerated wealth building - jammulinksnews.com
Why is Mainz Biomed N.V. stock attracting strong analyst attentionHigh-yield trading alerts - jammulinksnews.com
What institutions are buying Mainz Biomed N.V. stock nowFree Stock Market Swing Trading Strategies - Metal.it
Mainz Biomed N.V. Stock Analysis and ForecastStrong return on assets - jammulinksnews.com
Does Mainz Biomed N.V. stock pay reliable dividendsRapid capital growth - jammulinksnews.com
Should I buy Mainz Biomed N.V. stock before earningsHigh-impact stock picks - jammulinksnews.com
What drives Mainz Biomed N.V. stock priceUnprecedented market success - Autocar Professional
Mainz Biomed, CARE announce collaboration agreement - TipRanks
Mainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in Germany - Nasdaq
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewswire
Mainz Biomed Expands Early Cancer Detection Program to 19 German Health Insurers Through CARE Partnership - Stock Titan
When the Price of (MYNZ) Talks, People Listen - news.stocktradersdaily.com
What analysts say about Mainz Biomed N.V. stockConsistently profitable trades - jammulinksnews.com
Is Mainz Biomed N.V. a good long term investmentRapid growth trajectories - jammulinksnews.com
Why Mainz Biomed N.V. stock attracts strong analyst attentionFree Long-Term Wealth Growth Plan - beatles.ru
Mainz Biomed (NASDAQ:MYNZ) Trading Up 7% – Here’s Why - Defense World
Mainz Biomed Half Year 2025 Update: Accelerating FDA - GlobeNewswire
What makes Mainz Biomed N.V. stock price move sharplyFree Stock Market Expert Consultation - Newser
ARBI(arbipad) News and UpdatesProtected Capital Trading Plan - Newser
How Mainz Biomed N.V. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
Mainz Biomed reviews accomplishments for first half of 2025 - TipRanks
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.50%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):